e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Validation of the Bronchiectasis Impact Measure (BIM): a novel patient-reported outcome measure
Megan L. Crichton, Emily K. Dudgeon, Amelia Shoemark, James D. Chalmers
Source:
Eur Respir J, 57 (5) 2003156; 10.1183/13993003.03156-2020
Journal Issue:
May
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Megan L. Crichton, Emily K. Dudgeon, Amelia Shoemark, James D. Chalmers. Validation of the Bronchiectasis Impact Measure (BIM): a novel patient-reported outcome measure. Eur Respir J, 57 (5) 2003156; 10.1183/13993003.03156-2020
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Assessing the Asthma Impairment and Risk Questionnaire’s ability to predict exacerbations
Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations
Year: 2021
Development of the QOL-PCD: A cross-cultural patient-reported outcome measure for adults with primary ciliary dyskinesia
Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Year: 2014
Assessment of patient-centred outcome
Source: Annual Congress 2007 - PG20 - Pulmonary rehabilitation: an update according to the new ATS/ERS guidelines
Year: 2007
The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19
Source: Eur Respir J, 56 (1) 2001494; 10.1183/13993003.01494-2020
Year: 2020
Validation of the Clinical COPD Questionnaire (CCQ) in Swedish primary care
Source: Eur Respir J 2005; 26: Suppl. 49, 671s
Year: 2005
Title Development and preliminary psychometric testing of the Respiratory Nurse Sensitive Outcome Indicator tool (RNSOI) for patients with COPD.
Source: International Congress 2017 – Delivering person-centred care across the spectrum of respiratory nursing
Year: 2017
Assessing the Liverpool Respiratory Symptom Questionnaire in children with cystic fibrosis
Source: Eur Respir J 2012; 39: 899-905
Year: 2012
Translation and validation of the Quality-of-Life Bronchiectasis questionnaire in Swedish, and correlation with clinical outcomes.
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021
Development and pilot testing of a new 7-item cough severity patient reported outcome measure
Source: Annual Congress 2008 - COPD epidemiology
Year: 2008
Development of pediatric cross-cultural patient-reported outcome measures: QOL-PCD
Source: International Congress 2014 – Paediatric epidemiology: new insights into primary ciliary dyskinesia, prematurity and bronchiolitis
Year: 2014
Assessment of cognitive functions in stable COPD patients using PGI Memory Scale and to analyze for their correlation with patients‘ characteristics and BODE index
Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Year: 2012
Linguistic validation of the Clinical COPD Questionnaire (CCQ) for use in international studies
Source: Eur Respir J 2005; 26: Suppl. 49, 513s
Year: 2005
Development and validation of the Adolescent Asthma Quality of Life Questionnaire (AAQOL)
Source: Eur Respir J 2001; 17: 52-58
Year: 2001
Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD
Source: Eur Respir J , 49 (3) 1600773; DOI: 10.1183/13993003.00773-2016
Year: 2017
Assessment of Burden of COPD tool: evidence not perception
Source: Eur Respir J, 50 (1) 1700756; 10.1183/13993003.00756-2017
Year: 2017
Health-related quality of life in COPD: why both disease-specific and generic measures should be used
Source: Eur Respir J 2001; 18: 69-76
Year: 2001
Short Physical Performance Battery: Response to pulmonary rehabilitation and MCIDs in patients with COPD
Source: Virtual Congress 2021 – Pulmonary rehabilitation in asthma and COPD
Year: 2021
Impact of pulmonary endarterectomy (PEA) on quality of life as assessed by CAMbridge Pulmonary Hypertension Outcome Review (CAMPHOR)
Source: Eur Respir J 2006; 28: Suppl. 50, 403s
Year: 2006
Implementation of a Paediatric Bronchiectasis Severity Index (PBSI)
Source: Virtual Congress 2021 – Acute and chronic lung infections in children
Year: 2021
Measurement of COPD severity: further validation of a survey-based instrument
Source: Annual Congress 2007 - Epidemiology of COPD
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept